Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that the ongoing ion channel research collaboration with Boehringer Ingelheim has been extended with one year. "The p ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback